View Item 

Show simple item record

SH3KBP1‐binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c‐Cbl‐CIN85 complex
dc.contributor.authorFeng, Lifengen_US
dc.contributor.authorWang, Jin‐taoen_US
dc.contributor.authorJin, Hongchuanen_US
dc.contributor.authorQian, Kaixianen_US
dc.contributor.authorGeng, Jian‐guoen_US
dc.date.accessioned2011-11-10T15:38:45Z
dc.date.available2012-12-03T21:17:30Zen_US
dc.date.issued2011-10en_US
dc.identifier.citationFeng, Lifeng; Wang, Jin‐tao ; Jin, Hongchuan; Qian, Kaixian; Geng, Jian‐guo (2011). "SH3KBP1â binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of câ Cblâ CIN85 complex." Cell Biochemistry and Function 29(7): 589-596. <http://hdl.handle.net/2027.42/87120>en_US
dc.identifier.issn0263-6484en_US
dc.identifier.issn1099-0844en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/87120
dc.publisherJohn Wiley & Sons, Ltden_US
dc.subject.otherSH3KBP1‐Binding Protein 1en_US
dc.subject.otherCbl‐Interacting Protein of 85 KDa (CIN85)en_US
dc.subject.otherC‐Cblen_US
dc.subject.otherEpidermal Growth Factor Receptoren_US
dc.subject.otherDown‐Regulationen_US
dc.titleSH3KBP1‐binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c‐Cbl‐CIN85 complexen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid21830225en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/87120/1/cbf1792.pdf
dc.identifier.doi10.1002/cbf.1792en_US
dc.identifier.sourceCell Biochemistry and Functionen_US
dc.identifier.citedreferenceDikic I, Giordano S. Negative receptor signalling. Curr Opin Cell Biol 2003; 15: 128 – 135. doi: 10.1016/S0955‐0674(03)00004‐8.en_US
dc.identifier.citedreferenceHaglund K, Shimokawa N, Szymkiewicz I, Dikic I. Cbl‐directed monoubiquitination of CIN85 is involved in regulation of ligand‐induced degradation of EGF receptors. Proc Natl Acad Sci USA 2002; 99: 12191 – 12196. doi: 10.1073/pnas.192462299.en_US
dc.identifier.citedreferenceSchneider MR, Sibilia M, Erben RG. The EGFR network in bone biology and pathology. Trends Endocrinol Metab 2009; 20: 517 – 524. doi: 10.1016/j.tem.2009.06.008.en_US
dc.identifier.citedreferenceSoubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I. Cbl‐CIN85‐endophilin complex mediates ligand‐induced downregulation of EGF receptors. Nature 2002; 416: 183 – 187. doi: 10.1038/416183a.en_US
dc.identifier.citedreferenceWaterman H, Yarden Y. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Lett 2001; 490: 142 – 152. doi: 10.1016/S0014‐5793(01)02117‐2.en_US
dc.identifier.citedreferenceSaif MW. Colorectal cancer in review: the role of the EGFR pathway. Expert Opin Investig Drugs 2010; 19: 357 – 369. doi: 10.1517/13543781003593962.en_US
dc.identifier.citedreferenceThien CB, Langdon WY. Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2001; 2: 294 – 307. doi: 10.1038/35067100.en_US
dc.identifier.citedreferenceSzymkiewicz I, Kowanetz K, Soubeyran P, Dinarina A, Lipkowitz S, Dikic I. CIN85 participates in Cbl‐b‐mediated down‐regulation of receptor tyrosine kinases. J Biol Chem 2002; 277: 39666 – 39672. doi: 10.1074/jbc.M205535200.en_US
dc.identifier.citedreferencePennock S, Wang Z. A tale of two Cbls: interplay of c‐Cbl and Cbl‐b in epidermal growth factor receptor downregulation. Mol Cell Biol 2008; 28: 3020 – 3037. doi: 10.1128/MCB.01809‐07.en_US
dc.identifier.citedreferenceTan YH, Krishnaswamy S, Nandi S, et al. CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases. PLoS One 2010; 5: e8972. doi: 10.1371/journal.pone.0008972.en_US
dc.identifier.citedreferenceJozic D, Cardenes N, Deribe YL, Moncalian G, Hoeller D, Groemping Y, Dikic I, Rittinger K, Bravo J. Cbl promotes clustering of endocytic adaptor proteins. Nat Struct Mol Biol 2005; 12: 972 – 979. doi: 10.1038/nsmb1000.en_US
dc.identifier.citedreferenceTake H, Watanabe S, Takeda K, Yu ZX, Iwata N, Kajigaya S. Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c‐Cbl. Biochem Biophys Res Commun 2000; 268: 321 – 328. doi: 10.1006/bbrc.2000.2147.en_US
dc.identifier.citedreferenceWatanabe S, Take H, Takeda K, Yu ZX, Iwata N, Kajigaya S. Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes. Biochem Biophys Res Commun 2000; 278: 167 – 174. doi: 10.1006/bbrc.2000.3760S0006‐291X(00)93760‐4.en_US
dc.identifier.citedreferenceDikic I. CIN85/CMS family of adaptor molecules. FEBS Lett 2002; 529: 110 – 115. doi: 10.1016/S0014‐5793(02)03188‐5.en_US
dc.identifier.citedreferenceKowanetz K, Husnjak K, Holler D, et al. CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. Mol Biol Cell 2004; 15: 3155 – 3166. doi: 10.1091/mbc.E03‐09‐0683.en_US
dc.identifier.citedreferenceHall AB, Jura N, DaSilva J, Jang YJ, Gong D, Bar‐Sagi D. hSpry2 is targeted to the ubiquitin‐dependent proteasome pathway by c‐Cbl. Curr Biol 2003; 13: 308 – 314. doi: 10.1016/S0960‐9822(03)00086‐1.en_US
dc.identifier.citedreferenceHaglund K, Schmidt MH, Wong ES, Guy GR, Dikic I. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation. EMBO Rep 2005; 6: 635 – 641. doi: 10.1038/sj.embor.7400453.en_US
dc.identifier.citedreferenceFeng Q, Baird D, Peng X, Wang J, Ly T, Guan JL, Cerione RA. Cool‐1 functions as an essential regulatory node for EGF receptor‐ and Src‐mediated cell growth. Nat Cell Biol 2006; 8: 945 – 956. doi: 10.1038/ncb1453.en_US
dc.identifier.citedreferenceLiang Y, Kurakin A, Roizman B. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces. Proc Natl Acad Sci USA 2005; 102: 5838 – 5843. doi: 10.1073/pnas.0501253102.en_US
dc.identifier.citedreferenceWang HB, Wang JT, Zhang L, et al. P‐selectin primes leukocyte integrin activation during inflammation. Nat Immunol 2007; 8: 882 – 892. doi: 10.1038/ni1491.en_US
dc.identifier.citedreferenceWang B, Xiao Y, Ding BB, et al. Induction of tumor angiogenesis by Slit‐Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 2003; 4: 19 – 29. doi: 10.1016/S1535‐6108(03)00164‐8.en_US
dc.identifier.citedreferenceCriqui‐Filipe P, Ducret C, Maira SM, Wasylyk B. Net, a negative Ras‐switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de‐acetylation. EMBO J 1999; 18: 3392 – 3403. doi: 10.1093/emboj/18.12.3392.en_US
dc.identifier.citedreferenceZhang J, Zheng X, Yang X, Liao K. CIN85 associates with endosomal membrane and binds phosphatidic acid. Cell Res 2009; 19: 733 – 746. doi: 10.1038/cr.2009.51.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cbf1792.pdf
Size:
420.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.